Same-day Wellbutrin appointment in Florida

If you’re struggling with binge eating disorder (BED) and wondering whether you can access treatment online, you’re not alone. With telehealth now a mainstream option for mental health care, many people are asking: Can I get medication for binge eating disorder through a telehealth appointment? The short answer is yes—and for most people, it’s entirely legal, safe, and effective.

This comprehensive guide explains everything you need to know about accessing BED treatment via telehealth in 2026, including which medications are available, what the laws say, and how to navigate the process safely.

Understanding Binge Eating Disorder and Treatment Options

Binge eating disorder is the most common eating disorder in the United States, affecting millions of people. It’s characterized by recurrent episodes of eating large amounts of food in a short period while feeling a loss of control. Unlike bulimia, BED doesn’t involve purging behaviors.

According to DSM-5 criteria, a BED diagnosis requires:

• Eating an unusually large amount of food within a two-hour period
• Feeling out of control during these episodes
• Experiencing these episodes at least once a week for three months
• Distress about the binge eating behavior
• No regular compensatory behaviors like purging

Current Medication Options for BED

While therapy remains a cornerstone of BED treatment, medications can play an important supporting role. Currently, only one medication—Vyvanse (lisdexamfetamine)—has FDA approval specifically for binge eating disorder. However, because Vyvanse is a controlled stimulant with tighter prescribing restrictions via telehealth, many providers turn to off-label medications that have shown clinical promise:

Wellbutrin (Bupropion)

• Originally approved for depression and smoking cessation
• Studies suggest it can help reduce binge frequency
• Non-controlled medication, making telehealth prescribing straightforward
• Typical dosing allows for 90-day supplies with refills

Topamax (Topiramate)

• FDA-approved for seizures and migraines
• Research supports its use for impulse control and weight management in BED
• Also non-controlled, fully accessible via telehealth
• Usually started at low doses and gradually increased

Both medications are legal to prescribe via telehealth nationwide because they’re not controlled substances—meaning the strict federal in-person requirements don’t apply.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Telehealth Prescribing Laws: What You Need to Know

The Ryan Haight Act and Non-Controlled Medications

The Ryan Haight Act (2008) requires an in-person medical evaluation before prescribing controlled substances via telemedicine. This is where confusion often arises. Many people assume all telehealth prescriptions require an in-person visit, but that’s simply not true.

Here’s the critical distinction: The Ryan Haight Act restrictions apply only to controlled substances (Schedule II-V drugs like Adderall, Xanax, or opioids). Medications like Wellbutrin and Topamax are non-controlled legend drugs, which means they were never subject to these restrictions in the first place.

Current DEA Flexibility Through 2026

During the COVID-19 public health emergency, the DEA suspended the in-person requirement even for controlled substances prescribed via telehealth. That flexibility has been extended through December 31, 2026, giving lawmakers more time to finalize permanent rules.

However, for BED medications like Wellbutrin and Topamax, this extension doesn’t matter—they’ve always been legal to prescribe remotely. The federal government has never restricted telehealth prescribing of non-controlled medications.

State-by-State Telehealth Rules for BED Medications

While federal law sets the baseline, individual states can add their own requirements. Here’s what you need to know about key states:

States with No In-Person Requirements

California leads the way in telehealth flexibility. As of 2025, California explicitly allows prescribing based on telehealth examinations—even asynchronous (questionnaire-based) evaluations—as long as they meet the standard of care. For non-controlled medications, there’s no in-person visit requirement whatsoever.

New York similarly allows fully remote prescribing for non-controlled medications. While New York implemented new rules in May 2025 requiring in-person exams for controlled substances, these regulations explicitly exempt non-controlled drugs like Wellbutrin and Topamax.

Texas permits telehealth prescribing without in-person visits for non-controlled medications. Nurse practitioners and physician assistants can prescribe these BED medications under their prescriptive authority agreements.

States Requiring Periodic In-Person Follow-Ups

Alabama requires patients to see a provider in person within 12 months if they’ve had more than four telehealth visits for the same condition. However, this in-person visit can be with any collaborating provider, not necessarily the telehealth prescriber.

Georgia asks that providers attempt an annual in-person examination for ongoing telemedicine care, though initial evaluations can be done entirely via telehealth if the technology allows for an adequate assessment.

New Hampshire recently updated its laws in August 2025, explicitly allowing telehealth prescribing even for Schedule II-IV controlled substances, with a requirement for in-person follow-up within 12 months. For non-controlled BED medications, the rules are even more lenient.

The Bottom Line on State Requirements

In the vast majority of states, you can start and continue BED medication treatment entirely through telehealth without ever needing an in-person visit. Even in states with periodic in-person requirements, these typically apply only after sustained long-term treatment and can often be satisfied through local healthcare providers.

Who Can Prescribe BED Medications via Telehealth?

Physicians

Medical doctors (MDs) and doctors of osteopathy (DOs) can prescribe Wellbutrin and Topamax for binge eating disorder in all 50 states, provided they’re licensed in your state of residence.

Nurse Practitioners

The landscape for nurse practitioners has evolved dramatically in recent years. As of 2026, approximately 34 states plus Washington, D.C. grant nurse practitioners full practice authority—meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight.

States that recently joined this list include:

• Wisconsin (August 2025 APRN Modernization Act)
• Michigan (Public Act 47 of 2023, implemented by 2025)
• Louisiana (2025 implementation)
• Kansas (2025 implementation)

In states like California, New York, and New Hampshire, an NP can provide your complete BED evaluation and prescribe medications without any physician involvement.

In states requiring collaborative agreements (like Florida, Texas, Georgia, and Alabama), NPs work under formal agreements with physicians. This doesn’t typically affect your care experience—it’s a regulatory requirement happening behind the scenes—but you may see both providers’ names on your prescription.

Physician Assistants

PAs can prescribe non-controlled medications in all states under their supervising physician’s delegation. The level of independence varies by state, but for BED medications, PAs working with telehealth platforms can legally prescribe Wellbutrin and Topamax throughout the country.

The Telehealth Evaluation Process: What to Expect

Initial Assessment

A legitimate telehealth provider will conduct a thorough evaluation, typically lasting 30-45 minutes for an initial BED consultation. This isn’t a quick questionnaire—expect detailed questions about:

• Eating patterns and behaviors: Frequency of binge episodes, typical amounts consumed, triggers
• Medical history: Current medications, chronic conditions, past surgeries
• Mental health screening: Depression, anxiety, trauma history
• Contraindications: Seizure history, eating disorder history (bulimia/anorexia), pregnancy status
• Previous treatments: What you’ve tried before and how it worked

Many providers use standardized screening tools like the Eating Disorder Examination Questionnaire (EDE-Q) or Binge Eating Scale (BES) to establish baseline severity.

Safety Screenings and Contraindications

Your provider will screen for conditions that might make certain medications inappropriate:

For Wellbutrin (Bupropion):

• Absolute contraindications: History of bulimia, anorexia nervosa, or seizure disorders (these significantly increase seizure risk)
• Black box warning: Increased risk of suicidal thoughts in people under 25—close monitoring is essential
• Cautions: Heavy alcohol use, concurrent stimulant use, uncontrolled hypertension

For Topamax (Topiramate):

• Pregnancy risk: Topiramate is linked to birth defects, particularly cleft palate. Providers typically require effective contraception for women of childbearing age
• Cognitive effects: Can cause word-finding difficulties and concentration problems in some people
• Gradual titration required: Starting too high or stopping abruptly can trigger seizures

Documentation and Consent

Before prescribing, your provider will:

• Verify your identity and location (required in many states)
• Obtain informed consent for telehealth treatment
• Document that you meet DSM-5 criteria for BED
• Explain the off-label use of medications (since neither Wellbutrin nor Topamax is FDA-approved specifically for BED)
• Create a comprehensive treatment plan including follow-up schedule

This documentation goes into a secure electronic health record, just as it would in a traditional clinic setting.

Prescription Monitoring and Pharmacy Coordination

Do Providers Check Prescription Monitoring Programs?

Most states maintain Prescription Monitoring Programs (PMPs) that track controlled substance prescriptions. The good news: PMP checks are typically not required for non-controlled medications like Wellbutrin and Topamax.

However, many telehealth providers voluntarily review these databases as a safety precaution—for example, to ensure you’re not already on another antidepressant that might interact with Wellbutrin, or to identify other medications that could affect treatment.

Some states do require PMP checks when prescribing any medication in certain circumstances, but this is for the provider’s due diligence rather than a legal mandate for these specific drugs.

How Prescriptions Are Filled

Your telehealth provider will send your prescription electronically to a pharmacy of your choice—this is now required in most states. You’ll pick up your medication from a regular pharmacy (like CVS, Walgreens, or a local independent pharmacy) or through legitimate mail-order pharmacy services.

Red flag: Be wary of any telehealth service that wants to ship medication directly from their own warehouse. Legitimate services use licensed pharmacies to dispense FDA-approved medications.

Most providers can write prescriptions for 90-day supplies with refills up to one year for these non-controlled medications, though you’ll still need regular follow-up appointments.

Follow-Up Care and Ongoing Monitoring

Regular Check-Ins

Even though these medications aren’t controlled substances, responsible telehealth providers maintain regular contact with patients:

Typical follow-up schedule:

• 2-4 weeks after starting medication (to assess initial tolerance and side effects)
• Monthly visits for the first 3 months
• Every 2-3 months once stabilized
• Annual comprehensive reviews

What Providers Monitor

During follow-ups, your provider will track:

• Efficacy: Reduction in binge frequency and severity
• Side effects: Weight changes, mood effects, cognitive changes
• Vital signs: Some providers request you monitor blood pressure at home
• Laboratory work: Periodic metabolic panels may be recommended, especially with Topamax
• Mental health: Depression screening, suicidal ideation assessment (particularly important with Wellbutrin)

Adjusting Your Treatment Plan

BED treatment is rarely medication-only. Comprehensive care typically includes:

• Psychotherapy: Cognitive-behavioral therapy (CBT) is considered the gold standard for BED
• Nutritional counseling: Working with a registered dietitian
• Support groups: Connecting with others who understand the challenges
• Lifestyle modifications: Sleep, stress management, movement

A quality telehealth provider will discuss these complementary approaches and may coordinate with other members of your care team.

Safety Considerations and Red Flags

Recognizing Quality Telehealth Services

The telehealth industry has matured significantly, but not all services are created equal. After high-profile cases like the Done Global ADHD medication scandal in 2024—where executives were indicted for unsafe stimulant prescribing—regulators and responsible platforms have implemented stricter safeguards.

Signs of a reputable telehealth provider:

• Thorough initial evaluation (30+ minutes, not a 5-minute questionnaire)
• Licensed providers in your state
• Clear discussion of treatment alternatives, not just medications
• Transparent pricing and insurance billing
• Secure, HIPAA-compliant platform
• Regular follow-up protocols
• Willingness to refer to in-person care when appropriate

Warning signs to avoid:

• Guaranteed prescriptions before evaluation
• No discussion of therapy or other treatment modalities
• Unusually high doses prescribed immediately
• Prescribing multiple new medications simultaneously
• Pressure to use a specific pharmacy
• Lack of follow-up plans
• Providers who aren’t clearly licensed in your state

Who Should Not Pursue Telehealth BED Treatment

While telehealth works well for many people, some situations require in-person care:

Medical complexity:

• Severe obesity with unstable vital signs
• Uncontrolled diabetes or metabolic conditions requiring close monitoring
• Recent cardiac events
• Significant neurological symptoms

Psychiatric complexity:

• Active suicidal ideation requiring intensive monitoring
• Concurrent eating disorders with purging (anorexia, bulimia)
• Severe substance use disorders
• Psychotic symptoms

Pregnancy and breastfeeding:

• Topiramate is contraindicated in pregnancy
• Both medications require careful consideration during breastfeeding

Need for controlled medications:

• If evaluation suggests you need Vyvanse (the FDA-approved BED medication), telehealth options are more limited due to controlled substance restrictions

In these cases, your telehealth provider should refer you to appropriate in-person specialists.

How Klarity Health Supports Your BED Treatment Journey

At Klarity Health, we understand that accessing mental health care shouldn’t be complicated. Our platform connects you with licensed psychiatric providers who specialize in eating disorders and can evaluate you for BED treatment—including medications like Wellbutrin and Topamax when clinically appropriate.

What sets Klarity apart:

Provider availability: We offer appointments within days, not months, so you can start addressing your binge eating sooner rather than later.

Transparent pricing: Whether you’re using insurance or paying cash, you’ll know the cost upfront—no surprise bills.

Insurance and cash pay options: We accept most major insurance plans and offer affordable self-pay rates for those without coverage or who prefer not to use insurance.

Comprehensive approach: Our providers don’t just write prescriptions. They take time to understand your unique situation, discuss all treatment options (medication and therapy), and create a personalized care plan. Many can also provide referrals to therapists and dietitians who specialize in eating disorders.

Ongoing support: Regular follow-up appointments ensure your treatment is working and allow for adjustments as needed. You’re never on your own once you get a prescription.

Klarity’s providers are licensed in multiple states and stay current on the latest telehealth regulations, so you can feel confident your care is both legal and aligned with best practices.

The Future of Telehealth for BED Treatment

The regulatory landscape continues to evolve. The DEA is working on permanent rules for telehealth prescribing of controlled substances, expected by the end of 2026. However, these changes are unlikely to affect non-controlled BED medications like Wellbutrin and Topamax.

State legislatures are also expanding access. In 2025 alone, several states granted nurse practitioners full practice authority, and New Hampshire specifically modernized its telehealth laws to increase flexibility. The trend is clearly toward maintaining and expanding telehealth access for mental health and eating disorder treatment.

Taking the Next Step

If you’re struggling with binge eating disorder, telehealth offers a legitimate, legal, and often highly effective path to treatment. The key is choosing a reputable provider who conducts thorough evaluations, discusses all your options, and provides ongoing support.

Ready to explore your options?

• Research providers licensed in your state who specialize in eating disorders
• Prepare for your evaluation by documenting your eating patterns and symptoms
• Make a list of all current medications and health conditions
• Consider whether you’d benefit from therapy in addition to medication
• Ask questions about the provider’s approach, follow-up protocols, and what to expect

Remember: seeking help for BED is a sign of strength, not weakness. With the expanded access that telehealth provides, effective treatment is more accessible than ever before—and you don’t need to navigate it alone.

Research Currency Statement

Verified as of: January 4, 2026

Federal Regulations:

• DEA COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications, as these were never subject to Ryan Haight Act restrictions on telemedicine.

State Verification:

• Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, SC) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

Source Currency:

• 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

Flagged for Follow-Up:

• Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Top 5 Citations

1. HHS Press Release – ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026’ (January 2, 2026) – www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Health Law Blog – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions’ (August 2025) – www.sheppardhealthlaw.com/2025/08/articles/telehealth/

3. Center for Connected Health Policy – ‘Online Prescribing: State Telehealth Laws and Reimbursement Policies Database’ (Updated November-December 2025) – www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide Blog – ‘State-by-State Guide: Expanding Roles for PAs and NPs’ (Updated 2025) – blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. National Law Review – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions’ (2025) – natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12